Table 3. MMR and PMR by intervention stages in Guangzhou, China, 2008–2016.
Maternal mortality | Perinatal mortality | |||||
---|---|---|---|---|---|---|
Deaths (N) | Live Births (N) | Ratio (1 per 100,000 live births) | Deaths (N) | Births (N) | Rate (‰) | |
Baseline | 84 | 459,043 | 18.3 | 3,368 | 461,985 | 7.3 |
Stage 1 | 107 | 897,469 | 11.9 | 5,347 | 902,147 | 5.9 |
Stage 2 | 47 | 555,178 | 8.5 | 2,921 | 557,800 | 5.2 |
Z | −4.3680 (p < 0.001) | −13.1420 (p < 0.001) |
The p-value was obtained from the Cochran-Armitage trend test.
Baseline: January 2008–September 2010; Stage 1: October 2010–September 2014; Stage 2: October 2014–December 2016.
MMR was defined as the number of maternal deaths (during pregnancy or within 42 days of termination of pregnancy, except for accidental deaths) per 100,000 live births; PMR was defined as the number of stillbirths (≥28 weeks of gestation) and early neonatal deaths (0–6 days) per 1,000 births.
Abbreviations: MMR, maternal mortality ratio; PMR, perinatal mortality rate